|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM360341330 |
| 003 |
DE-627 |
| 005 |
20231226082818.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202305226
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1201.xml
|
| 035 |
|
|
|a (DE-627)NLM360341330
|
| 035 |
|
|
|a (NLM)37534386
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Li, Ting
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A Universal Chemotactic Targeted Delivery Strategy for Inflammatory Diseases
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 03.08.2023
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a ErratumFor: Adv Mater. 2022 Nov;34(47):e2206654. - PMID 36122571
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 650 |
|
4 |
|a Published Erratum
|
| 700 |
1 |
|
|a Liu, Zhiyong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hu, Jinglei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Lin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Tiantian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tang, Qianqian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yu, Bixia
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhao, Bo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mao, Chun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wan, Mimi
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 35(2023), 31 vom: 03. Aug., Seite e2305226
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:35
|g year:2023
|g number:31
|g day:03
|g month:08
|g pages:e2305226
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202305226
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 35
|j 2023
|e 31
|b 03
|c 08
|h e2305226
|